share_log

ZyVersa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund Ltd. (1)(8.6%)

ZyVersa Therapeutics | SC 13G:超過5%持股股東披露文件-L1 Capital Global Opportunities Master Fund Ltd. (1)(8.6%)

美股sec公告 ·  2023/07/18 16:01
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息